Related Experiment Video
Updated: May 8, 2026
11:11
Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Human RGM249-derived small RNAs potentially regulate tumor malignancy.
Norimasa Miura1, Mika Shimizu, Waka Shinoda
1Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Nucleic Acid Therapeutics
|August 31, 2013
Summary
Researchers explored RGM249-derived molecules for cancer therapy. These molecules, delivered via drug delivery systems (DDS), inhibited tumor growth, metastasis, and promoted differentiation, suggesting a novel anticancer approach.
Area of Science:
- Molecular Biology
- Oncology
- RNA Therapeutics
Background:
- The noncoding RNA gene RGM249 is implicated in regulating cancer cell differentiation.
- Investigating RGM249 derivatives offers potential for new cancer treatments.
Purpose of the Study:
- To evaluate the efficacy of 3 microRNA-like molecules derived from RGM249 in reducing malignant properties of cancer cells.
- To assess the role of drug delivery systems (DDS) in delivering these molecules in vivo.
Main Methods:
- Utilized small interfering RNAs (siRNAs) targeting RGM249 derivatives.
- Employed cationized drug delivery systems (DDS) with atelocollagen or gelatin hydrogel microspheres.
- Administered siRNAs systemically in immunodeficient KSN/Slc mice models.
Main Results:
- DDS effectively delivered siRNAs to tumor cells, inhibiting growth, inducing apoptosis, and suppressing neovascularization and metastasis.
- Systemic siRNA administration reduced the metastatic potential of cancer cells.
- Cotransfection of siRNAs regulated genes associated with differentiation, pluripotency, and proliferation.
Conclusions:
- RGM249-derived oligonucleotides show potential in regulating cancer metastasis, proliferation, and differentiation in vivo.
- The tested siRNAs represent a promising new avenue for anticancer therapeutic strategies.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...